Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 6, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for September 6, 2006 Subscribe to this News Feed      
 

Fibromyalgia’s New Foe: High-Tech Medical Device Shows Increasing Efficacy for the Debilitating Symptoms of FMS

Fibromyalgia patients worldwide are seeing rapid improvement in their symptoms from a high-tech medical device.
However, it is hard to dispute the present data. 90% of the patients treated with the CES reported improvement in quality of life.

Cincinnati, OH (PRWEB) September 6, 2006 -- Fibromyalgia patients worldwide are seeing rapid improvement in their symptoms from a high-tech medical device indicated for depression, anxiety, insomnia, and pain.

depression_anxiety.jpg

The device employs two distinct technologies, Microcurrent Electrotherapy Technology (MET) and Cranial Electrotherapy Stimulation (CES), to treat psychological and physical symptoms. It has been used by professional sports teams, such as the Dallas Cowboys and Indiana Pacers, and pain specialists to treat pain disorders successfully. Recently, rheumatologists have begun prescribing it for their fibromyalgia patients who are reporting significant results.

“The results are so positive in such a difficult-to-treat population that one becomes skeptical,” says Robert S. Katz, M.D. of Chicago, IL while responding to a study on the device. “However, it is hard to dispute the present data. 90% of the patients treated with the CES reported improvement in quality of life.”

While the degree of improvement varies for each patient, some patients are seeing life-changing results.

Joellen Cross, a patient with chronic fibromyalgia, saw almost a complete turnaround rather quickly. “I received my unit last July, and went from despondent and weary from the chronic pain, to nearly pain-free, and elated at the change, in less than a week,” she says. “And the depression I was experiencing more and more as the chronic pain progressed is all but eliminated.”

Fibromyalgia is seen in about 3 to 6% of the population and there are few effective treatments available. Given that many fibromyalgia patients cannot tolerate medication, this device is seen as a welcome non-drug approach by patients and physicians to treat its symptoms.

Marilyn Lins, M.D., of Utica Neurological Surgery, Inc. in Tulsa, Oklahoma said that the results she has been obtaining have been close to miraculous. A pain specialist, Dr. Lins reported on several fibromyalgia patients who have had sufficient pain relief to resume normal activities with as little as two 20 minute treatments per week. One of her patients stopped limping after only one treatment. Dr. Lins said, “[CES has forever changed my treatment approach. I have never experienced results like I have had in the past two months.”

“Some rheumatology practices are writing orders for these devices for their entire fibromyalgia caseloads,” said Karl Moeller, President and CEO of Moeller Medical, LLC, distributor of the device. “Our goal is to have every fibromyalgia patient try our treatment. Most will benefit to some degree and some will have dramatic improvement.”

Moeller Medical has set up two informational websites for patients and physicians to learn about the device, Depression Treatment Now and Anxiety Treatment Now, and plans to follow up with informative sites later this year for insomnia and chronic pain.

About Moeller Medical, Inc.

Moeller Medical, LLC is a privately held company based in Cincinnati, OH. Moeller Medical is dedicated to bringing safe, quality healthcare products to the patient and medical community and is proud to offer a completely non-invasive drug-free form of psychological and pain treatment. For more information; visit http://www.depressiontreatmentnow.com or http://www.anxietytreatmentnow.com.

For more information:
Karl Moeller
President and CEO
Moeller Medical, LLC
513-297-4975 ext. 101

###

See the original story at: http://www.prweb.com/releases/2006/09/prweb433645.htm

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/RmFsdS1DcmFzLUZhbHUtTG92ZS1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Karl Moeller
Moeller Medical, LLC
513-297-4975 +101
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright